The Neuroanatomy of Alzheimer's Disease

Reviews in the Neurosciences

Volumn 2, Issue 2, 1989, Pages 101-122

  Pearson, R C A ^a   Powell, T P S ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

ALZHEIMER DISEASE; HUMAN; NEUROANATOMY; NEUROFIBRILLARY TANGLE; OLFACTORY SYSTEM; REVIEW; SENILE PLAQUE;

EID: 0024369761     PISSN: 3341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.1989.2.2.101     Document Type: Article

References (220)

1. Tomlinson BE, Corsellis JAN. Ageing and the dementias. In: Hume Adams J, Corsellis JAN, Duchen LW, eds, Greenfield's Neuropathology. New York: John Wiley and Sons, 1984; 951-1025.
2. Katzman R. The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol 1976; 33: 217-18.
3. Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983; 14: 497-506.
4. Bowen DM, Smith CB, White P, Davison AN. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976; 99: 459-96.
5. Davies P, Maloney AJF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; ii: 1403.
6. Struble RG, Lehmann J, Mitchell SJ, McKinney M, Price DL, Coyle JT, DeLong MR. Basal forebraian neurons provide major cholinergic innervation of primate neocortex. Neurosci Lett 1986; 66: 215-20.
7. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981; 10: 122-26.
8. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215: 1237-39.
9. Arendt T, Bigl V, Arendt A, Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol (Berl) 1983; 61: 101-08.
10. Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbaim AF, Tomlinson BE. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol sci 1983; 54: 277-89.
11. Doucette R, Fisman M, Hachinski VC, Merskey H. Cell loss from the nucleus basalis of Meynert in Alzheimer's disease. Can J Neurol sci 1986; 13: 435-40.
12. Etienne P, Robitaille Y, Wood P, Gauthier S, Nait NPV, Quirion R. Nucleus basalis loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neurosci 1986; 19: 1279-91.
13. Mann DMA, Yates PO. Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders. Human Neurobiol 1986; 5: 147-58.
14. Mann DMA, Yates PO, Marcyniuk B. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Develop 1984; 25: 189204.
15. Mann DMA, Yates PO, Marcyniuk B. A comparison of changes in the nucleus basalis and locus coeruleus in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1984; 47: 201-03.
16. Mann DMA, Yates PO, Marcyniuk B. A comparison of nerve cell loss in cortical and subcortical structures in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1986; 49: 310-12.
17. McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurol 1984; 34: 74145.
18. Nagai T, McGeer PL, Peng JH, McGeer EG, Dolman CE. Choline acetyltransferase immunohistochemistry in brains of Alzheimer's disease patients and controls. Neurosci Lett 1983; 36: 195-99.
19. Pearson RCA, Sofroniew MV, Cuello AC, Powell TPS, Esiri MM, Wilcock GK. Persistence of cholinergic neurons in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res 1983; 289; 375-79.
20. Perry RH, Candy JM, Perry EK, Irving D, Blessed G, Fairbaim AF, Tomlinson BE. Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease. Neurosci Lett 1982; 33: 311-15.
21. Rasool CG, Svendsen CN, Selkoe DJ. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease. Ann Neurol 1986; 20: 482-88.
22. Rinne JO, Paljarvi L, Rinne UK. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J Neurol sci 1987; 79: 67-76.
23. Rogers JD, Brogan D, Mirra SS. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol 1985; 17: 163-70.
24. Rossor MN, Svendsen C, Hunt SP, Mountjoy CQ, Roth M, Iversen LL. The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci Lett 1982; 28: 217-22.
25. Saper CB, German DC, White CL. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type. Possible role in cell loss. Neurology 1985; 35: 1089-95.
26. Tagliavani F, Pilleri G. Basal nucleus of Meynert. A neuropathological study in Alzheimer's disease, simple senile dementia, Pick's disease and Huntington's Chorea. J Neurol sci 1983; 62: 243-60.
27. Whitehouse PJ, Hedreen JC, White CL, Clark AW, Price DL. Neuronal loss in the basal forebrain cholinergic system is more marked in Alzheimer's disease than in senile dementia of the Alzheimer type. Ann Neurol 1983; 14: 149.
28. Wilcock GK, Esiri MM, Bowen DM, Smith CCT. The nucleus basalis in Alzheimer's disease: cell counts and cortical biochemistry. Neuropathol Appl Neurobiol 1983; 9: 175-79.
29. Pearson RCA, Gatter KC, Powell TPS. Retrograde cell degeneration in the basal nucleus in monkey and man. Brain Res 1983; 261: 321-26.
30. Sofroniew MV, Pearson RCA, Powell TPS. The cholinergic nuclei of the basal forebrain of the rat: normal structure, development and experimentally induced degeneration. Brain Res 1987; 411: 310-31.
31. Pearson RCA, Gatter KC, Brodai P, Powell TPS. The projection of the basal nucleus of Meynert upon the neocortex in the monkey. Brain Res 1983; 259: 132-36.
32. Arendt T, Bigl V, Tennstedt A, Arendt A. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neurosci 1985; 14: 1-14.
33. Wilcock GK, Esiri MM, Bowen DM, Smith CCT. Alzheimer's disease. Correlations of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J Neurol sci 1982; 57: 407-17.
34. Henke H, Lang W. Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 1983; 267: 281-91.
35. Burger PC. The limbic system in Alzheimer's disease. In: Katzman R, ed, Biological Aspects of Alzheimer's Disease (Vol. 15, Banbury Report). Cold Spring Harbor, 1983; 3744.
36. Hooper MW, Vogel FS. The limbic system in Alzheimer's disease. A neuropathological investigation. Am J Pathol 1976; 85: 1-20.
37. Norberg A, Nyberg P, Adolfsson P, Winblad B. Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile. J Neural Transm 1987; 69: 19-32.
38. Palmer AM, Proctor AW, Stratmann GC, Bowen DM. Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci Lett 1986; 66: 199-204.
39. Sofroniew MV, Pearson RCA. Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in the rat. Brain Res 1985; 339: 186-90.
40. Pearson RCA, Powell TPS. Anterograde vs retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease. J Neural Transm 1987; [suppl] 24: 139-46.
41. Nakano I, Hirano A. Parkinson's disease: neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 1984; 15: 415-18.
42. Whitehouse PJ, Hedreen JC, White CL, Price DL. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983; 13: 24348.
43. Nakani I, Hirano A. Neuron loss in the nucleus basalis of Meynert in Parkinsonism-dementia complex of Guam. Ann Neurol 1983; 13: 87-91.
44. Tagliavani F, Pilleri G, Bouras C, Constantinidis J. The basal nucleus of Meynert in patients with progressive supranuclear palsy. Neurosci Lett 1984; 44: 3742.
45. Tagliavani F, Pilleri G, Gemignani F, Lechi A. Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy. Acta Neuropathol (Berl) 1983; 61: 157-60.
46. Uhl GR, McKinney M, Hedreen JC, White CL, Coyle JT, Whitehouse PJ, Price.DL. Dementia pugilistica: loss of basal forebrain cholinergic neurons and cortical cholinergic markers. Ann Neurol 1982; 12: 99.
47. Uhl GR, Hilt DC, Hedreen JC, Whitehouse PJ, Price DL. Pick's disease (lobar sclerosis): depletion of neurons in the nucleus basalis of Meynert. Neurology 1983; 33: 1470-73.
48. Clark AW, Parhad IM, Folstein SE, Whitehouse PJ, Hedreen JC, Price DL, Chase GA. The nucleus basalis in Huntington's disease. Neurology 1983; 33: 1262-67.
49. Mann DMA, Yates PO, Marcyniuk B. The nucleus basalis of Meynert in multi-infarct (vascular) dementia. Acta Neuropathol (Berl) 1986; 71: 332-37.
50. Casanova MF, Walker LC, Whitehouse PJ, Price DL. Abnormalities of the nucleus basalis in Down's syndrome. Ann Neurol 1985; 18: 310-13.
51. Averback P. Lesions of the nucleus ansae peduncularis in neuropsychiatrie disease. Arch Neurol 1981; 38: 230-35.
52. Tagliavani F, Pilleri G. Neuronal loss in the basal nucleus of Meynert in a patient with olivopontocerebellar atrophy. Acta Neuropathol (Berl) 1985; 66: 127-33.
53. Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 1982; 32: 164-68.
54. Hirano A, Zimmerman HM. Alzheimer's neurofibrillary changes. A topographic study. Arch Neurol 1962; 7: 22742.
55. Ishii T. Distribution of Alzheimer's neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol (Berl) 1966; 6: 181-87.
56. Mann DMA, Lincoln J, Yates PO, Stamp JE, Toper S. Changes in the monoamine containing neurones of the human CNS in senile dementia. Br J Psychiatry 1980; 136: 53341.
57. Mann DMA, Yates PO, Hawkes J. The noradrenergic system in Alzheimer and multi-infarct dementias. J Neurol Neurosurg Psychiatry 1982; 45: 113-19.
58. Marcyniuk B, Mann DMA, Yates PO. Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci Lett 1986; 64: 247-52.
59. Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease. J Neurol sci 1981; 51: 279-87.
60. Tomlinson BE, Irving D, Blessed G. Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol sci 1981; 49: 419-28.
61. Hardy JA, Mann DMA, Wester P, Winblad B. An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease. Neurobiol Aging 1986; 7: 489-502.
62. Curcio CA, Kemper T. Nucleus raphe dorsalis in dementia of the Alzheimer type: neurofibrillary changes and neuronal packing density. Neuropathol Exp Neurol 1984; 43: 359-68.
63. Mann DMA, Yates PO. Serotonin nerve cells in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1983; 46: 96.
64. Yamamoto T, Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol 1985; 17: 573-77.
65. Brodai A. Neurological Anatomy in Relation to Clinical Medicine. New York: Oxford University Press, 1981.
66. Lindvall O, Bjorklund A. General organization of cortical monoamine systems. In: Descarries L, Reader TR, Jasper
67. HH, eds, Monoamine Innervation of Cerebral Cortex. New York; Alan R Liss, 1984; 9-40.
68. Morrison JH, Foote SL, Bloom FE. Regional, laminar, developmental, and functional characteristics of noradrenaline and serotonin innervation patterns in monkey cortex. In: Descarries L, Reader TR, Jasper HH, eds, Monoamine Innervation of Cerebral Cortex. New York: Alan R Liss, 1984; 61-75.
69. Mann DMA, Yates PO, Marcyniuk B. Dopaminergic neurotransmitter systems in Alzheimer's disease and Down's syndrome at middle age. J Neurol Neurosurg Psychiatry 1987; 50: 341-44.
70. Ditter SM, Mirra SS. Neuropathological and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987; 37: 754-60.
71. Simchowicz T. Sur la signification des plaques seniles et sur la formule senile de l'ecorce cerebrale. Rev Neurol 1924; 41: 221-27.
72. Saper CB, German DC. Hypothalamic pathology in Alzheimer's disease. Neurosci Lett 1987; 74: 364-70.
73. German DC, White CL, Sparkman DR. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neurosci 1987; 21: 305-12.
74. Jones EG. The Thalamus. New York: Plenum, 1985.
75. Lhermitte J, Trelles J-O. Plaques seniles de l'infundibulum. Rev neurol 1934; 61: 547-50.
76. Rudelli RD, Ambler MW, Wisniewski HM. Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol (Berl) 1984; 64: 273-81.
77. Neumann MA, Cohn R. Incidence of Alzheimer's disease in a large mental hospital. Relation to senile psychosis and psychosis with cerebral arteriosclerosis. Arch Neurol Psychiatry 1953; 69: 615-36.
78. Jones EG. Anatomy of the cerebral cortex: columnar input-output organization. In: Schmitt 0, Worden G, Adelman G, Dennis SG, eds, The Organization of the Cerebral Cortex. Cambridge: MIT, 1981; 199-235.
79. Pearson RCA, Brodai P, Gatter KC, Powell TPS. The organization of the connections between the cortex and the claustrum in the monkey. Brain Res 1982; 234: 435-41.
80. Goldman-Rakic PS, Selemon LD. Topography of corticostriatal projections in nonhuman primates and implications for functional parcellaiton of the neostriatum. In: Jones EG, Peters A, eds, Cerebral Cortex, Vol. 5. New York: Plenum, 1986; 447-66.
81. Kemp JM, Powell TPS. The cortico-striate projection in the monkey. Brain 1970; 93: 52546.
82. Van Hoesen GW, Yeterian EH, Larizzo-Mourey R. Widespread cortico-striate projections from temporal cortex of the rhesus monkey. J Comp Neurol 1981; 199: 205-19.
83. Yeterian EH, Van Hoesen GW. Cortico-striate projections in the rhesus monkey; the organization of certain corticocaudate connections. Brain Res 1978; 139: 43-63.
84. Goldman PS, Nauta WJH. An intricately patterned prefronto-caudate projection in the rhesus monkey. J Comp Neurol 1977; 171: 369-86.
85. Ball MJ. Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia. A quantitative study. Acta Neuropathol (Berl) 1977; 37: 111-18.
86. Braak H, Braak E. On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol (Berl) 1985; 68: 325-32.
87. Brun A. An overview of light and electron microscopic changes. In: Reisberg B, ed, Alzheimer's Disease: The Standard Reference. New York: Free Press, 1983; 3747.
88. Brun A, Englund E. Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading. Histopath 1981; 5: 549-64.
89. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986; 19: 253-62.
90. Brun A, Gustafson L. Distribution of cerebral degeneration in Alzheimer's disease. Arch Psychiatrie Nervenkrank 1876; 223: 15-33.
91. Brun A, Gustafson L. Limbic lobe involvement in presenile dementia. Arch Psychiatrie Nervenkrank 1978; 226: 79-93.
92. Goodman L. Alzheimer's disease. A clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J Nerv Ment Dis 1953; 117: 97-130.
93. Herzog AG, Kemper TL. Amygdaloid changes in aging and dementia. Arch Neurol 1980; 37: 625-29.
94. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: cell-specific pathology isolates the hippocampalformation. Science 1984; 225: 1168-70.
95. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR: Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986; 20: 472-81.
96. Kemper TL. Organization of the neuropathology of the amygdala in Alzheimer's disease. In: Katzman R, ed, Biological Aspects of Alzheimer's Disease. Banbury Report 15, Cold Spring Harbor, 1983; 31-35.
97. Malamud W, Lowenberg K. Alzheimer's disease. A contribution to its etiology and classification. Arch neurol Psychiatry 1929; 21: 805-27.
98. Margolis G. Senile cerebral disease. A critical survey of traditional concepts based upon newer technics. Lab Invest 1959; 8: 335-70.
99. McLardy T. Memory function in hippocampal gyributnot in hippocampi. Internat J Neurosci 1970; 1: 113-18.
100. Reyes PF, Golden GT, Fagel PL, Fariello RG, Katz L, Carner E. The prepiriform cortex in dementia of the Alzheimer type. Arch neurol 1987; 44: 64445.
101. Tomlinson BE, Blessed G, Roth M. Observations on the brains of demented old people. J Neurol sci 1970; 11: 20542.
102. Wilcock GK, Esiri MM. Plaques, tangles and dementia. A quantitative study. J Neurol sci 1982; 56: 343-56.
103. Esiri MM, Pearson RCA, Powell TPS. The cortex of the primary auditory in Alzheimer's disease. Brain Res 1986; 366: 385-87.
104. Lewis DA, Campbell MJ, Terry RD, Morrison JH. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci 1987; 7: 1799-1808.
105. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad sci 1985; 82: 4531-34.
106. Rogers J, Morrison JH. Quantitative morphology and regional and laminar distributions of senile plaques in Alzheimer's disease. J Neurosci 1985; 5: 2801-08.
107. Duyckaerts C, Hauw J-J, Bastenaire F, Piette F, Poulain C, Rainsard V, Javoy-Agid F, Berthaux P. Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (Berl) 1986; 70: 249-56.
108. Jones EG, Powell TPS. An anatomical study of converging sensory pathways within the cerebral cortex of the monkey. Brain 1970; 93; 793-820.
109. Van Hoesen GW. The parahippocampal gyrus. New observations regarding its cortical connections in the monkey. Trends Neurosci 1982; 5: 345-50.
110. Hyman BT, Kromer LJ, Van Hoesen GW. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease. Ann Neurol 1987; 21: 259-67.
111. Van Hoesen GW, Pandya DN. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents. Brain Res 1975; 95: 25-38.
112. Van Hoesen GW, Pandya DN. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. 111. Efferent connections. Brain Res 1975; 95: 39-59.
113. Terry RD, Peck A, DeTeresa RD, Schechter R, Horoupian DS. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10: 184-92.
114. Jones EG. Laminar distribution of cortical efferent cells. In: Peters A, Jones EG, eds, Cerebral Cortex, Vol. I. New York: Plenum, 1984; 521-53.
115. Barbas H. Pattern in the laminar origin of corticocortical connections. J Comp Neurol 1986; 252: 415-22.
116. Duyckaerts C, Hauw J-J, Piette F, Rainsard V, Poulain V, Berthaux P, Escourolle R. Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length. Acta Neuropathol (Berl) 1985; 66: 72-74.
117. Heyman A, Wilkinson WE, Hurwitz BJ, Helms MJ, Haynes CS, Utley CM, Gwyther LP. Early-onset Alzheimer's disease: clinical predictors of institutionalization and death. Neurology 1987; 37: 980-84.
118. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ARDRA work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurol 1984; 34: 939-44.
119. Ulrich J. Alzheimer changes in nondemented patients younger than sixty-five: possible early stages of Alzheimer's disease and senile dementia of Alzheimer type. Ann Neurol 1985; 17: 273-77.
120. Mann DMA, Tucker CM, Yates PO. The topographic distribution of senile plaques and neurofibrillary tangles in the brains of nondemented persons of different ages. Neuropathol Appl Neurobiol 1987; 13: 123-39.
121. Ulrich J. Senile plaques and neurofibrillary tangles of the Alzheimer type in nondemented individuals at presenile age. Gerontol 1982; 28: 86-90.
122. Esiri MM, Wilcock GK. The olfactory bulbs in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1984; 47: 56-60.
123. Simpson J, Yates CM, Gordon A, StClair DM. Olfactory tubercle choline acetyltransferase activity in Alzheimer-type dementia, Down's syndrome and Huntington's disease. J Neurol Neurosurg Psychiatry 1984; 47: 1138.
124. Corwin J, Serby M, Conrad P, Rotrosen J. Olfactory recognition deficit in Alzheimer's and Parkinsonian dementias. IRCS Med sci 1985; 13: 260.
125. Corwin J, Serby M, Rotrosen J. Olfactory deficits in AD: What we know about the nose. Neurobiol Aging 1986; 7: 580-82.
126. Gilbert AN. Involvement of the olfactory system in Alzheimer's disease. Bull Clin Neurosci 1985; 50: 38.
127. Gilbert AN. The neuropsychology of olfaction in Alzheimer's disease. Neurobiol Aging 1986; 7: 578-79.
128. Koss E. Olfactory dysfunction in Alzheimer's disease. Develop Neuropsychol 1986; 2: 89-99.
129. Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and recognition in Alzheimer's disease. Lancet 1987;i: 622.
130. Peabody CA, Tinkleberg JR. Olfactory deficits and primary degenerative dementia. Am J Psychiatry 1985; 142: 524-25.
131. Serby M, Corwin J, Conrad P, Rotrosen J. Olfaction in Alzheimer's and Parkinsonian dementia. Am J Psychiatry 1985; 146: 781-82.
132. Serby M, Corwin J, Novatt A, Conrad P, Rotrosen J. Olfaction in dementia. J Neurol Neurosurg Psychiatry 1985; 48: 848-49.
133. Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand 1974; 50: 539-47.
134. Warner MD, Peabody CA, Flattery JJ, Tinkleberg JR. Olfactory deficits and Alzheimer's disease. Biol Psychiatry 1986; 21: 116-18.
135. Roberts E. Alzheimer's disease may begin in the nose and may be caused by aluminosilicates. Neurobiol Aging 1986; 7: 561-67.
136. Bodian D, Howe HA. An experimental study of the role of neurones in the dissemination of poliomyelitis virus in the nervous system. Brain 1940; 63: 135-62.
137. Esiri MM, Tomlinson AH. Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory and trigeminal pathways after infection of facial skin in mice. J Neurol sci 1984; 64: 213-17.
138. Lundh D, Kristensson K, Norrby E. Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and sendai viruses. Neuropathol Appl Neurobiol 1987; 13: 111-22.
139. Tomlinson AH, Esiri MM. Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory pathways in mice. J Neurol sci 1983; 60: 473-84.
140. Balin BJ, Broadwell RD, Saloman M, El-Kalliny M. Avenues for entry of peripherally administered protein to the central nervous system in mouse, rat, and squirrel monkey. J Comp Neurol 1986; 251: 260-80.
141. Perl DP, Good PF. Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet 1987; i: 1028.
142. Broadwell RD, Brightman MW. Cytochemistry of undamaged neurons transporting exogenous protein in vivo. J Comp Neurol 1979; 185; 31-74.
143. Aggleton JP. A description of the amaygdalo-hippocampal interconnections in the macaque monkey. Exp Brain Res 1986; 64: 515-26.
144. Aggleton JP, Burton MJ, Passingham RE. Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta). Brain Res 1980; 190: 347-68.
145. Amaral DG, Price JL. Amygdalo-cortical projections in the monkey (Macaca fasciclaris). J Comp Neurol 1984; 230: 165-96.
146. Bayer SA. Hippocampal region. In: Paxinos G, ed, The Rat Nervous System, Vol. 1 Forebrain and Midbrain. Sydney: Academic, 1985; 335-52.
147. DeOlmos J, Alheid GF, Beltramino CA. Amygdala. In: Paxinos G, ed, The Rat Nervous System, Vol 1 Forebrain and Midbrain. Sydney: Academic, 1985; 223-334.
148. Herzog AG, Van Hoesen GW. Temporal neocortical afferent connections to the amygdala in the rhesus monkey. Brain Res 1976; 115: 57-69.
149. Ottersen OP. Afferent connections to the amygdaloid complex of the rat and cat: II. Afferents from the hypothalamus and the basal telencephalon. J Comp Neurol 1980; 194: 267-89.
150. Ottersen OP. Afferent connections to the amaygdaloid complex in the rat with some observations in the cat: III. Afferents from the lower brain stem. J Comp Neurol 1981; 202: 335-56.
151. Ottersen OP. Connections of the amygdala of the rat. IV. Corticoamygdaloid and intraamaygdaloid connections as studied with axonal transport of horseradish peroxidase. J Comp Neurol 1982; 205: 30-48.
152. Ottersen OP, Ben-Ari Y. Afferent connections to the amygdaloid complex of the rat and cat. I Afferents from the thalamus. J Comp Neurol 1979; 187: 401-24.
153. Powell TPS, Cowan WM, Raisman G. The cerebral olfactory connexions. J Anat 1965; 99: 791-813.
154. Room P, Groenewegen HJ. Connections of the parahippocampal cortex. I. Cortical afferents. J Comp Neurol 1986; 251: 415-50.
155. Room P, Groenewegen HJ. Connections of the parahippocampal cortex in the cat. II. Subcortical afferents. J Comp Neurol 1986; 251: 451-73.
156. Switzer RC, de Olmos J, Heimer L. Olfactory systems. In: Paxinos G, ed, The Rat Nervous System, Vol. 1 Forebrain and Midbrain. Sydney: Academic Press, 1985; 1-36.
157. Turner BH, Mishkin M, Knapp M. Organization of the amygdalopetal projections from modality-specific cortical association areas in the monkey. J Comp Neurol 1980; 191: 515-43.
158. Van Hoesen GW, Pandya DN. Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. I. Temporal lobe afferents. Brain Res 1975; 95: 1-24.
159. Witter MP, Groenewegen HJ. Connections of the parahippocampal cortex in the cat. III. Cortical and thalamic efferents. J Comp Neurol 1986; 252: 1-31.
160. Witter MP, Groenewegen HJ. Connections of the parahippocampal cortex in the cat. IV. Subcortical efferents. J Comp Neurol 1986; 251: 51-77.
161. Witter MP, Room P, Groenewegen HJ, Lohman AHM. Connections of the parahippocampal cortex in the cat. V. Intrinsic connections; comments on input / output connections with the hippocampus. J Comp Neurol 1986; 252: 78-94.
162. Geddes JW, Monaghan DT, Cotman CW, Lott IT, Lim RC, Chui HC. Plasticity of hippocampal circuitry in Alzheimer's disease. Science 1985; 230: 1179-81.
163. Murray EA, Mishkin M. Visual recognition in monkeys following rhinal cortical ablations combined with either amygdalectomy or hippocampectomy. J Neurosci 1986; 6: 1991-2003.
164. Geinisman Y, Bondareff W, Telser A. Transport of [3H] fucose labelled glycoproteins in the septo-hippocampal pathway of young adult and senescent rats. Brain Res 1977; 125: 182-86.
165. Geinisman Y, Bondareff W, Telser A. Diminished axonal transport of glycoproteins in the senescent rat brain. Mech Ageing Dev 1977; 6: 363-78.
166. Esiri MM. Typical and atypical viruses in the aetiology of senile dementia of the Alzheimer's type. In: Ulrich J, ed, Interdisciplinary Topics in Gerontology. Zurich: Karger, 1987; in press.
167. De Boni U, Crapper DR. Paired helical filaments of the Alzheimer type in cultured neurones. Nature 1978; 271: 566-68.
168. Esiri MM. Herpes simplex encephalitis. An immunohistochemical study of the distribution of viral antigen within the brain. J Neurol sci 1982; 54: 209-26.
169. Sloper JJ, Barnard RO, Eglin RP, Powell TPS. Abnormal tubular structures associated with the granular endoplasmic reticulum of neocortical neurons in a biopsy from a patient with Alzheimer's disease. Neuropathol Appl Neurobiol 1986; 12: 491-501.
170. Kay DWK. Heterogeneity in Alzheimer's disease: epidemiological and family studies. Trends Neurosci 1987; 10: 194-95.
171. St. George-Hyslop PH, Tanzi RE, Polinsky HJ, Haines JL, Nee L, Watkins PC, Myers RH, Feldman RG, Pollen D, Drachman D, Growdon J, Bruni A, Foncin J-F, Salmon D, Frommelt P, Amaducci L, Sorbi S, Piacentini S, Stewart GD, Hobbs WJ, Conneally PM, Gusella JF. The genetic defect causing familial Alzheimer's disease maps on chromosome 21. Science 1987; 235: 885-90.
172. Heyman A, Wilkinson WE, Hurwitz BJ, Schmechel D, Sigmon AH, Weinberg T, Helms MJ, Swift M. Alzheimer's disease: genetic aspects and associated clinical disorders. Ann Neurol 1983; 14: 507-15.
173. Mohs RC, Breitner JCS, Silverman JM, Davis KL. Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. Arch Gen Psychiatry 1987; 44: 405-08.
174. Burger PC, Vogel FS. The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 1973; 73: 457-576.
175. Mann DMA, Yates PO, Marcyniuk B. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol Appl Neurobiol 1984; 10: 185-207.
176. Wisniewski KE, Wisniewski HM, Wen GY. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 1985; 17; 278-82.
177. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC. Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 1987; 235: 877-80.
178. Kang J, Lemaire H-G, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K-H, Multhaup G, Beyreuther K, Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987; 325: 733-36.
179. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL. Amyloid ß protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 1987;, 235: 880-84.
180. Guiroy DC, Miyazaki M, Multhaup G, Fischer P, Garruto RM, Bayreuther K, Masters CL, Simms G, Gibbs CJ, Gajdusek DC. Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequences. Proc Natl Acad sci 1987; 84: 2073-77.
181. Delabar J-M, Goldgaber D, Lamour Y, Nicole A, Huret J-L, De Gouchy J, Brown P, Gajdusek DC, Sinet P-M. βamyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science 1987; 235: 1390-92.
182. Bahamanyar S, Higgins GA, Goldgaber D, Lewis DA, Morrison JH, Wilson MC, Shankar SK, Gajdusek DC. Localization of amyloid ß protein messenger RNA in brains from patients with Alzheimer's disease. Science 1987; 237: 77-80.
183. Tanzi RF, St George-Hyslop PH, Haines JL, Polinsky RJ, Nee L, Foncin J-F, Neve RL, McClatchey AI, Conneally PM, Gusella JF. The genetic defect in familial Alzheimer's disease is not tightly linked to the amyloid |3-protein gene. Nature 1987; 329: 156-57.
184. Van Broeckhoven C, Genthe AM, Vandenberghe A, Horsthemke B, Backhovens H, Raeymaekers P, Van Hul W, Martin JJ, Salbaum M, Multhaup G, Masters CL, Beyreuther K, Gurling HMD, Mullan MJ, Holland A, Barton A, Irving N, Williamson R, Richards J, Hardy JA. Failure of familial Alzheimer's disease to segregate with the A4-amyloid gene in several European families. Nature 1987; 329: 153-55.
185. Podlinsky MB, Lee G, Selkoe DJ. Gene dosage of the amyloid ß precursor protein in Alzheimer's disease. Science 1987; 238: 669-71.
186. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Neve RL, Pollen D, Drachman D, Growdon J, Cupples LA, Nee L, Myers RH, O'Sullivan D, Watkins PC, Amos JA, Deutsch CK, Bodfish JW, Kinsbourne M, Feldman RG, Bruni A, Amaducci L, Foncin J-F, Gusella JF. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science 1987; 238: 664-66.
187. Tanzi RF, Bird ED, Latt SA, Neve RL. The amyloid β-protein gene is not duplicated in brains from patients with Alzheimer's disease. Science 1987; 238: 666-69.
188. Nee LE, Eldridge R, Sunderland T, Thomas CB, Katz D, Thompson KE, Weingartner H, Weiss H, Julian C, Cohen R. Dementia of the Alzheimer type: clinical and family studies of 22 twin pairs. Neurol 1987; 37: 359-63.
189. Heston LL, Mastri AR. The genetics of Alzheimer's disease. Associations with hematologic malignancy and Down's syndrome. Arch Gen Psychiatry 1977; 34: 976-81.
190. Heston LL, Mastri AR, Anderson VE, White J. Dementia of the Alzheimer type. Clinical genetics, natural history, and associated conditions. Arch Gen Psychiatry 1981; 38: 1085-90.
191. Sutnick AI, London WT, Blumberg BS, Gerstley BJS. Susceptibility to leukemia: immunologic factors in Down's syndrome. J Natl Cancer Inst 1971; 47: 923-33.
192. Hsia DY-Y, Justice P, Smith GF, Dowben RM. Down's syndrome. A critical review of the biochemical and immunological data. Am J Dis child 1971; 121: 153-61.
193. Rundle AT, Clothier B, Sudell R. Serum IgD levels and infections in Down's syndrome. Clin Chim Acta 1971; 35: 389-93.
194. Sutnick AI, London T, Blumberg BS. Effects of host and environment on immunoglobulins in Down's syndrome. Arch Intern Med 1969; 124: 722-25.
195. Yokoyama M, Ball C, Lou K, Alepa FP. Immunogenetic studies on mongolism. Am J Ment Def 1967; 71: 597-601.
196. Tan YH, Tischfield J, Ruddle FH. The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21. J Exp Med 1973; 137: 317-30.
197. Weitkamp LR, Nee L, Keats B, Polinsky RJ, Guttormsen S. Alzheimer disease: evidence for susceptibility loci on chromosomes 6 and 14. Am J Hum Genet 1983; 35: 443-53.
198. Leibowitz S, Hughes RAC. Immunology of the Nervous System. London: Edward Arnold, 1983; 250-53.
199. MacDonald SM, Goldstone AH, Morris JE, Exton-Smith AN, Calard RE. Immunological parameters in the aged and in Alzheimer's disease. Clin Exp Immunol 1982; 49: 123-28.
200. Makinodan T, Kay MMB. Age influence on the immune system. Adv Immunol 1980; 29: 287-330.
201. Wade AW, Szewczuk MR. Aging, idiotype repertoire shifts, and compartmentalization of the mucosal-associated lymphoid system. Adv Immunol 1984; 36: 143-188.
202. Doty RL, Shaman P, Applebaum SL, Giberson R, Sikorski L, Roseberg L. Smell identification ability: changes with age. Science 1984; 226: 144143.
203. Bhatnagar KP, Kennedy RC, Baron G, Greenberg RA. Number of mitral cells and bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat Ree 1987; 218: 73-87.
204. Whalley LJ, Holloway S. Non-random geographical distribution of Alzheimer's presenile dementia in Edinburgh, 1953-76. Lancet 1985; i: 578.
205. Crapper DR, Quittkat S, DeBoni U. Altered chromatin conformation in Alzheimer's disease. Brain 1979; 102: 483-95.
206. Crapper-McLachlan DR, DeBoni U. Etiologic factors in senile dementia of the Alzheimer type. In: Amaducci L, Davison AN, Antuono P, eds, Aging of the Brain and Dementia (Vol. 13, Aging). New York: Raven, 1980; 173-81.
207. Bowen DM, Smith CB, White P, Flack RHA, Carrasco LH, Gedye JL, Davison AN. Chemical pathology of the organic dementias II. Quantitative estimation of cellular changes in postmortem brains. Brain 1977; 100: 427-53.
208. Doebler JA, Markesbery WR, Anthony A, Rhoads RE. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease. J Neuropathol Exp Neurol 1987; 46: 28-39.
209. Sajdel-Sulkowska EM, coughlin JF, Staton DM, Marotta CA. In vitro protein synthesis by messenger RNA from the Alzheimer's disease brain. In: Katzman R, ed, Biological Aspects of Alzheimer's Disease (Banbury Report 15). Cold Spring Harbour, 1983; 193-200.
210. Taylor GR, Carter GL, Crow TJ, Johnson JA, Fairbaim AF, Perry EK, Perry RH. Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation. J Neurol Neurosurg Psychiatry 1987; 50: 356.
211. Suzuki K, Katzman R, Korey SR. Chemical studies on Alzheimer's disease. J Neuropathol Exp Neurol 1965; 24: 211-24.
212. Sumpter PQ, Mann DMA, Davies CA, Yates PO, Snowden JS, Neary D. An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease. Neuropathol Appl Neurobiol 1986; 12: 305-19.
213. Sumpter PQ, Mann DMA, Davies CA, Neary D, Snowden JS, Yates PO. A quantitative study of the ultrastructure of pyramidal neurons of the cerebral cortex in Alzheimer's disease in relationship to the degree of dementia. Neuropathol Appl Neurobiol 1986; 12: 321-29.
214. Cross AJ, Crow TJ, Dawson JM, Ferrier IN, Johnson JA, Peters TJ, Reynolds GP. Subcellular pathology of human neurodegenerative disorders: Alzheimer-type dementia and Huntington's disease. J Neurochem 1986; 47: 882-89.
215. Cross AJ, Crow TJ, Johnson JA, Dawson JM, Peters TJ. Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia. J Neurol sci 1985; 71: 13743.
216. Cross AJ, Crow TJ, Peters TJ. Cortical neurochemistry in Alzheimer-type dementia. Prog Brain Res 1986; 70: 153-69.
217. Emory CR, Thomas AA, Frey WH. Ganglioside monoclonal antibody (A2B5) labels Alzheimer's neurofibrillary tangles. Neurology 1987; 37: 768-72.
218. Gray EG, Barbosa MP, Roher A. Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol 1987; 13: 91-110.
219. Saper CB, Warner BH, Gorman DC. Axonal and transneuronal transport in the transmission of neurological disease: Potential role in system degenerations, including Alzheimer's disease. Neurosci 1987; 23: 389-98.
220. Mann DMA, Tucker CH, Yates PO. Alzheimer's disease: An olfactory connection? Mech Ageing Devel 1988; 42: 1-15.